These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16398165)

  • 1. [Alzheimer's disease and treatment of vascular risk factors].
    de Leeuw FE; van Norden AG; van der Flier WM; Olde Rikkert MG; Scheltens P
    Ned Tijdschr Geneeskd; 2005 Dec; 149(51):2844-9. PubMed ID: 16398165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vascular risk factors and Alzheimer disease risk: epidemiological studies review].
    Cowppli-Bony P; Dartigues JF; Orgogozo JM
    Psychol Neuropsychiatr Vieil; 2006 Mar; 4(1):47-60. PubMed ID: 16556518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vascular risk factors and Alzheimer's disease].
    Regalado Doña PJ; Azpiazu Artigas P; Sánchez Guerra ML; Almenar Monfort C
    Rev Esp Geriatr Gerontol; 2009; 44(2):98-105. PubMed ID: 19268394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of Alzheimer's disease].
    Dufouil C; Alpérovitch A
    Rev Prat; 2005 Nov; 55(17):1869-78. PubMed ID: 16396227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular risk aggravates the progression of Alzheimer's disease in a Chinese cohort.
    Li J; Zhang M; Xu ZQ; Gao CY; Fang CQ; Deng J; Yan JC; Wang YJ; Zhou HD
    J Alzheimers Dis; 2010; 20(2):491-500. PubMed ID: 20164563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of cholesterol in the pathogenesis of Alzheimer's disease: role of statins.
    Pregelj P
    Psychiatr Danub; 2008 Jun; 20(2):162-7. PubMed ID: 18587285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood pressure and Alzheimer's disease].
    Pasquier F; Leys D
    Rev Neurol (Paris); 1998 Nov; 154(11):743-51. PubMed ID: 9894287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular risk factors and Alzheimer's disease.
    Cechetto DF; Hachinski V; Whitehead SN
    Expert Rev Neurother; 2008 May; 8(5):743-50. PubMed ID: 18457531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors for cognitive impairment].
    Cicconetti P; Riolo N; Priami C; Tafaro L; Ettore E
    Recenti Prog Med; 2004 Nov; 95(11):535-45. PubMed ID: 15598092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of MMSE score change in Alzheimer's disease: influence of education and vascular risk factors.
    Roselli F; Tartaglione B; Federico F; Lepore V; Defazio G; Livrea P
    Clin Neurol Neurosurg; 2009 May; 111(4):327-30. PubMed ID: 19036496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease.
    Deschaintre Y; Richard F; Leys D; Pasquier F
    Neurology; 2009 Sep; 73(9):674-80. PubMed ID: 19720973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease risk factors and progression of Alzheimer's disease.
    Abellan van Kan G; Rolland Y; Nourhashémi F; Coley N; Andrieu S; Vellas B
    Dement Geriatr Cogn Disord; 2009; 27(3):240-6. PubMed ID: 19246908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and preventive interventions for Alzheimer disease: state of the science.
    Daviglus ML; Plassman BL; Pirzada A; Bell CC; Bowen PE; Burke JR; Connolly ES; Dunbar-Jacob JM; Granieri EC; McGarry K; Patel D; Trevisan M; Williams JW
    Arch Neurol; 2011 Sep; 68(9):1185-90. PubMed ID: 21555601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk and protective factors for sporadic Alzheimer's disease.
    Stozická Z; Zilka N; Novák M
    Acta Virol; 2007; 51(4):205-22. PubMed ID: 18197729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total cholesterol levels and the risk of mild cognitive impairment and Alzheimer's disease.
    Panza F; Capurso C; D'Introno A; Colacicco AM; De Candia D; Capurso A; Solfrizzi V
    J Am Geriatr Soc; 2007 Jan; 55(1):133-5. PubMed ID: 17233704
    [No Abstract]   [Full Text] [Related]  

  • 17. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
    Kidd PM
    Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the treatment of vascular risk factors slow cognitive decline in Alzheimer's disease patients?
    Richard F; Pasquier F
    J Alzheimers Dis; 2012; 32(3):765-72. PubMed ID: 22886010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of statins in Alzheimer's disease.
    Kandiah N; Feldman HH
    J Neurol Sci; 2009 Aug; 283(1-2):230-4. PubMed ID: 19321181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.